IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Imunon, Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Aug 11, 2026

$0.98−0.04 (-3.43%)

Close on Oct 19, 2026

Market cap: $4.95M
P/E (TTM): –
Dividend yield: –

Imunon, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Cash & Equivalents	8.78	5.87	5.84	11	20	17	6.88	13	11	2.62	9.27	13	5.72	15	20	1.14	6.92
Short-Term Investments	–	–	9.86	21	30	–	7.94	14	13	1.68	11	24	37	8.04	8.04	0.40	–
Cash & Short-Term Investments	8.80	5.90	16	33	57	17	15	28	24	4.30	20	37	43	23	28	1.53	6.92
Receivables	0	0	0	0	–	0	–	–	–	–	–	–	–	–	–	–	–
Prepaid Expenses & Other	–	–	–	–	–	–	–	–	–	0.12	0.10	0.24	0.56	0.19	0.20	0.49	–
Other Current Assets	–	–	–	–	–	–	–	–	–	0.12	–	–	–	0.19	0.20	–	–
Total Current Assets	11	8.01	18	37	52	19	16	28	24	4.51	20	38	44	24	32	2.03	–
Property, Plant & Equipment	0.53	0.54	0.75	0.55	0.48	0.29	0.41	0.18	0.18	0.46	0.85	1.17	0.83	1.11	0.78	0.38	–
Gross Property, Plant & Equipment	1.81	1.74	2.85	3.19	3.83	3.52	3.50	3.15	3.01	2.98	2.91	2.80	2.10	2.04	1.43	–	–
Accumulated Depreciation	-1.28	-1.20	-2.10	-2.64	-3.36	-3.23	-3.10	-2.97	-2.84	-2.51	-2.06	-1.63	-1.26	-0.92	-0.64	-1.05	–
Operating Lease Right-of-Use Assets	0.98	1.12	1.60	0.16	0.69	1.05	1.43	0.40	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	1.98	1.98	1.98	1.98	1.98	1.98	1.98	–	–	–	–	–
Intangible Assets	–	–	–	–	–	0.11	0.34	0.57	0.80	1.02	1.59	–	0.02	0.03	0.04	0.04	–
Deferred Tax Assets	–	–	1.28	1.57	1.38	1.85	1.82	–	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	1.03	1.17	2.93	6.65	22	18	22	–	0.01	0.01	–	–	–	0.60	0.36	–	–
Total Assets	12	9.72	22	44	74	38	38	47	48	31	49	67	46	25	33	2.53	–
Accounts Payable	–	–	3.52	3.59	2.55	2.24	2.86	3.02	3.42	2.88	2.83	3.48	1.45	2.34	4.01	4.55	–
Accrued Expenses	2.82	3.03	3.39	4.79	3.17	2.46	2.30	2.59	2.28	2.48	1.92	2.46	2.71	–	–	–	–
Current Portion of Leases	0.41	0.45	0.49	0.23	0.55	0.43	0.39	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	–	–	–	–	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.50	–	–	–	–
Total Current Liabilities	4.62	4.79	7.39	10	6.77	6.75	7.89	6.11	6.20	8.42	9.32	10	4.67	5.01	6.15	6.80	–
Long-Term Debt	–	–	–	4.61	5.85	3.93	7.96	9.42	–	–	2.35	6.05	5.00	3.66	0.07	0.06	–
Long-Term Leases	0.60	0.69	1.14	–	0.23	0.71	1.14	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	1.01	1.14	1.62	0.23	0.78	1.14	1.53	1.90	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	–	–	–	–	–	–	–	0.06	0.07	0.01	0.05	0.29	0.47	0.45	0.07	0	–
Total Liabilities	5.23	5.47	8.53	15	18	19	24	26	21	24	29	34	14	13	6.46	7.10	–
Total Debt	–	–	–	4.61	5.85	3.93	7.96	9.42	–	–	2.35	6.05	5.00	3.66	0.07	0.06	–
Preferred Stock	–	–	–	–	–	–	–	–	–	–	0	0	0	–	–	–	–
Common Stock	0.03	0.01	0.09	0.07	0.06	0.03	0.23	0.19	0.17	0.02	0.23	0.20	0.14	–	–	–	–
Additional Paid-In Capital	428	411	402	398	389	331	305	294	288	248	240	230	203	171	153	99	–
Retained Earnings	-421	-407	-388	-369	-333	-312	-291	-274	-262	-241	-218	-195	-169	-156	-124	-101	–
Treasury Stock	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09	-1.38	-2.06	-2.42	-2.69	-2.88	-3.08	–
Comprehensive Income & Other	0	0	0.06	0.03	-0.01	–	0.04	0.03	-0.01	–	0.00	-0.02	-0.04	-0.13	-0.28	-0.02	–
Shareholders' Equity	7.06	4.24	13	29	56	19	15	21	27	6.73	20	33	32	12	26	-4.58	10
Total Equity	7.06	4.24	13	29	56	19	15	21	27	6.73	20	33	32	12	26	-4.58	10
Total Liabilities & Equity	12	9.72	22	44	74	38	38	47	48	31	49	67	46	25	33	2.53	–
Shares Outstanding(shares)	3.42	0.97	9.40	7.44	5.77	2.71	1.55	1.26	1.15	0.15	0.06	0.05	0.04	0.02	0.02	0.01	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -256.4%

Financial strength

Current ratio: 1.59
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 115.1%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 1.47
Dividend yield: –